Art. -Nr.: HY-N6967

Levomenol

(Synonyms: (-)-α-Bisabolol)

Kundenbewertung

Based on 1 Customer Validation

Levomenol ((-)-α-Bisabolol), a monocyclic sesquiterpene alcohol, exerts antioxidant, anti-inflammatory, and anti-apoptotic activities. Levomenol also has neuroprotective effects and prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice. Levomenol attenuates nociceptive behaviour and central sensitisation in a rodent model of trigeminal neuropathic pain. Orally active.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit: 99.22%
CAS. Nr.: 23089-26-1
Formel: C₁₅H₂₆O
Molecular Weight:222.37

Speicherung:

Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month

Levomenol Chemical Structure

CAS. Nr.: 23089-26-1

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
- In Vivo
Chemical Information
Lösungsmittel & Löslichkeit
- In Vitro
- In Vivo
Reinheit & Dokumentation
Verweise
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Cellular Effect

Cell Line	Type	Value	Description	References
HeLa	IC₅₀	73 μM Compound: 1	Inhibition of IFNgamma-induced STAT3 activation in human HeLa cells expressing p4xM67-tk-Luc treated 30 mins before TNFalpha challenge measured after 6 hrs Inhibition of IFNgamma-induced STAT3 activation in human HeLa cells expressing p4xM67-tk-Luc treated 30 mins before TNFalpha challenge measured after 6 hrs	[PMID: 22309250]
HT-29	GI₅₀	>100 μM Compound: alpha-bisabolol	Cytotoxicity against human HT-29 cells by sulforhodamine B assay Cytotoxicity against human HT-29 cells by sulforhodamine B assay	[PMID: 20413188]
K562	GI₅₀	6.37 μM Compound: alpha-bisabolol	Cytotoxicity against human K562 cells by sulforhodamine B assay Cytotoxicity against human K562 cells by sulforhodamine B assay	[PMID: 20413188]
Leukemia cell	IC₅₀	14 μM Compound: BISA	Cytotoxicity against ALL/AML patient derived primary leukemia cells after 24 hrs by LDH release assay Cytotoxicity against ALL/AML patient derived primary leukemia cells after 24 hrs by LDH release assay	[PMID: 30096653]
MCF7	GI₅₀	>100 μM Compound: alpha-bisabolol	Cytotoxicity against human MCF7 cells by sulforhodamine B assay Cytotoxicity against human MCF7 cells by sulforhodamine B assay	[PMID: 20413188]
NCI-H460	GI₅₀	>100 μM Compound: alpha-bisabolol	Cytotoxicity against human NCI-H460 cells by sulforhodamine B assay Cytotoxicity against human NCI-H460 cells by sulforhodamine B assay	[PMID: 20413188]
NIH3T3	GI₅₀	84 μg/mL Compound: 2	Growth inhibition of mouse 3T3 cells Growth inhibition of mouse 3T3 cells	[PMID: 11678668]
OVCAR-3	GI₅₀	>100 μM Compound: alpha-bisabolol	Cytotoxicity against human OVCAR-3 cells by sulforhodamine B assay Cytotoxicity against human OVCAR-3 cells by sulforhodamine B assay	[PMID: 20413188]
UACC-62	GI₅₀	>100 μM Compound: alpha-bisabolol	Cytotoxicity against human UACC62 cells by sulforhodamine B assay Cytotoxicity against human UACC62 cells by sulforhodamine B assay	[PMID: 20413188]

In Vivo

Levomenol ((-)-α-Bisabolol) (100-200 mg/kg; p.o.; one day before and 1 h after pMCAO; once daily for the following five day; Male Swiss mice) significantly reduces the infarcted area and neurological deficits caused by pMCAO^[1]. pMCAO: permanent media cerebral artery occlusion.
(-)-α-bisabolol exerts anti-inflammatory effects by reducing astrogliosis, MPO activity, and TNF-α and iNOS production^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Chemical Information

CAS. Nr. 23089-26-1
Appearance Liquid (Density: 0.9211 g/cm³)
Molecular Weight 222.37
Formel C₁₅H₂₆O
Color Colorless to light yellow
SMILES

C[C@@](O)([C@@]1([H])CCC(C)=CC1)CC/C=C(C)/C
Synonyms

(-)-α-Bisabolol
Structure Classification
- Terpenoids
- Sesquiterpenes
Initial Source
- Plants
- other families
Versand

Room temperature in continental US; may vary elsewhere.

Speicherung

Pure form	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Lösungsmittel & Löslichkeit

In Vitro:

DMSO : 100 mg/mL (449.70 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

4.4970 mL

22.4850 mL

44.9701 mL

5 mM

0.8994 mL

4.4970 mL

8.9940 mL

10 mM

0.4497 mL

2.2485 mL

4.4970 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

In Vivo:

Select the appropriate dissolution method based on your experimental animal and administration route.

Stock Solution Working Solution

For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.

Protocol 1

Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline

Solubility: ≥ 2.5 mg/mL (11.24 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.

Protocol 2

Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)

Solubility: ≥ 2.5 mg/mL (11.24 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.

Protocol 3

Add each solvent one by one: 10% DMSO 90% Corn Oil

Solubility: ≥ 2.5 mg/mL (11.24 mM); Clear solution

This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown). If the continuous dosing period exceeds half a month, please choose this protocol carefully.

Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL Corn oil, and mix evenly.

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage Dosage
mg/kg
Animal Weight (Per Animal) Animal Weight (Per Animal)
g
Dosing Volume (Per Animal) Dosing Volume (Per Animal)
μL
Number of Animals Number of Animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Please enter your animal formula composition:

%
DMSO +

Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
%
+
+
%
Tween-80 + +
%
Saline +

The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).

Working solution concentration: 0.22 mg/mL

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (271 KB)
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Fernandes MYD, et al. (-)-α-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice. Eur J Pharmacol. 2019 Jan 5;842:270-280. [Content Brief]

[2]. Melo LT, et al. (-)-α-Bisabolol reduces nociception and trigeminal central sensitisation in acute orofacial neuropathic pain induced by infraorbital nerve injury. Life Sci. 2019 Jun 15;227:122-128. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	4.4970 mL	22.4850 mL	44.9701 mL	112.4252 mL
	5 mM	0.8994 mL	4.4970 mL	8.9940 mL	22.4850 mL
	10 mM	0.4497 mL	2.2485 mL	4.4970 mL	11.2425 mL
	15 mM	0.2998 mL	1.4990 mL	2.9980 mL	7.4950 mL
	20 mM	0.2249 mL	1.1243 mL	2.2485 mL	5.6213 mL
	25 mM	0.1799 mL	0.8994 mL	1.7988 mL	4.4970 mL
	30 mM	0.1499 mL	0.7495 mL	1.4990 mL	3.7475 mL
	40 mM	0.1124 mL	0.5621 mL	1.1243 mL	2.8106 mL
	50 mM	0.0899 mL	0.4497 mL	0.8994 mL	2.2485 mL
	60 mM	0.0750 mL	0.3748 mL	0.7495 mL	1.8738 mL
	80 mM	0.0562 mL	0.2811 mL	0.5621 mL	1.4053 mL
	100 mM	0.0450 mL	0.2249 mL	0.4497 mL	1.1243 mL

Keywords

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

Levomenol

MCE Bioactive Compound Library

Natural Product Library Plus

Biologische Aktivität

Chemical Information

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

Levomenol

MCE Bioactive Compound Library

Natural Product Library Plus

Biologische Aktivität

Chemical Information

Lösungsmittel & Löslichkeit

Reinheit & Dokumentation

Verweise

Help & FAQs

Complete Stock Solution Preparation Table

Levomenol Related Classifications

HY-N6967 Related Classifications